Inhaled Iloprost in Adults With Abnormal Pulmonary Pressure and Associated With Idiopathic Pulmonary Fibrosis

PHASE2CompletedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

April 30, 2005

Primary Completion Date

October 31, 2006

Study Completion Date

October 31, 2006

Conditions
Pulmonary FibrosisPulmonary Hypertension
Interventions
DRUG

Iloprost Inhalation Solution (Ventavis)

Trial Locations (17)

10029

Mount Sinai Medical Center, New York

15213

University of Pittsburgh School of Medicine, Pittsburgh

22042

Inova Research Center, Church Falls

27710

Duke University Medical Center, Durham

33136

University of Miami, Miami

35294

University of Alabama at Birmingham, Birmingham

37232

Vanderbilt University Medical, Nashville

48109

University of Michigan Health System, Ann Arbor

52242

University of Iowa College of Medicine, Iowa City

55905

Mayo Clinic Rochester, Rochester

60637

The University of Chicago, Chicago

70112

Tulane University, New Orleans

75708

University of Texas Health Center at Tyler, Tyler

77030

Baylor College of Medicine, Houston

90095

UCLA School of Medicine, Los Angeles

92037

University of California, San Diego, San Diego

94143

University of California, San Francisco, San Francisco

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Actelion

INDUSTRY

NCT00109681 - Inhaled Iloprost in Adults With Abnormal Pulmonary Pressure and Associated With Idiopathic Pulmonary Fibrosis | Biotech Hunter | Biotech Hunter